Chapter 4. Natriuretic Peptides and Inflammatory Markers for Risk Stratification in Patients with Ischemic Heart Disease

  1. James A. de Lemos MD Associate Professor of Medicine Coronary Care Unit Director
  1. Torbjørn Omland MD, PhD, MPH and
  2. Torgun Wæhre MD, PhD

Published Online: 13 JAN 2009

DOI: 10.1002/9781444300208.ch4

Biomarkers in Heart Disease

Biomarkers in Heart Disease

How to Cite

Omland, T. and Wæhre, T. (2008) Natriuretic Peptides and Inflammatory Markers for Risk Stratification in Patients with Ischemic Heart Disease, in Biomarkers in Heart Disease (ed J. A. de Lemos), Blackwell Publishing Ltd., Oxford, UK. doi: 10.1002/9781444300208.ch4

Editor Information

  1. University of Texas Southwestern Medical Center Dallas, TX, USA

Author Information

  1. Department of Medicine, Akershus University Hospital, Lørenskog, Faculty of Medicine, University of Oslo, Oslo, Norway

Publication History

  1. Published Online: 13 JAN 2009
  2. Published Print: 18 APR 2008

Book Series:

  1. The AHA Clinical Series

Book Series Editors:

  1. Elliott Antman

ISBN Information

Print ISBN: 9781405175715

Online ISBN: 9781444300208

SEARCH

Keywords:

  • natriuretic peptides and inflammatory markers;
  • biology of B-type natriuretic peptide (BNP);
  • BNPs and myocardial ischemia;
  • prognostic value of BNPs in ACS;
  • natriuretic peptides and timing of measurements;
  • therapeutic decision making impact;
  • BNP measurements in stable IHD for prognostic assessment;
  • C-reactive protein (CRP);
  • natriuretic peptides for risk stratification in ischemic heart disease

Summary

This chapter contains sections titled:

  • Introduction

  • B-type natriuretic peptides

  • C-reactive protein (CRP)

  • Conclusions

  • References